SCHEMBL25515746

SCHEMBL25515746

CCCCCC/C(=N\OC(C)=O)C(=O)c1ccc(-n2c3ccc(C(=O)/C(CCCCCC)=N/OC(C)=O)cc3c3cc(C(=O)c4ccc(OC(C)=O)cc4)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
PTGS2 P35354 1/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
ELANE P08246 1/20 0.34
LMNA P02545 1/20 0.32
PKM P14618 1/20 0.32
HTT P42858 1/20 0.32
RECQL P46063 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PLA2G4A P47712 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 1/20 0.32
PSEN1 P49768 1/20 0.32
PSEN2 P49810 1/20 0.32
APH1B Q8WW43 1/20 0.32
NCSTN Q92542 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515757 0.95 CNR2 (0.43) CNR2KMT2AMEN1PTGS2SMN1; SMN2
SCHEMBL23801788 0.90 CNR2 (0.43) CNR2KMT2APTGS2SMN1; SMN2ELANE
SCHEMBL23801780 0.90 CNR2 (0.43) CNR2KMT2APTGS2SMN1; SMN2ELANE
SCHEMBL23801742 0.86 CNR2 (0.42) CNR2KMT2AMEN1POLBSMN1; SMN2
SCHEMBL23802410 0.86 CNR2 (0.41) CNR2KMT2AMEN1PTGS2SMN1; SMN2
SCHEMBL23802446 0.85 CNR2 (0.46) CNR2PLA2G4ANPC1CNR1
SCHEMBL23801783 0.84 CNR2 (0.41) CNR2KMT2AMEN1SMN1; SMN2ELANE
SCHEMBL23801754 0.84 CNR2 (0.38) CNR2KMT2APTGS2SMN1; SMN2ELANE
SCHEMBL23801343 0.84 CNR2 (0.44) CNR2KMT2AMEN1NPC1PSEN1
SCHEMBL23802486 0.84 CNR2 (0.42) CNR2SMN1; SMN2LMNAPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142648-A1 OXIME ESTER PHOTOINITIATORS OCIAD1, OCIAD2, OXER1 CNR2 663/4885KMT2A 3437/4885MEN1 4834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.